Chori (8014) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
21 Jul, 2026Executive summary
Achieved record-high ordinary profit of ¥12.0 billion, profit before income taxes of ¥12.7 billion, and net profit attributable to owners of parent of ¥9.1 billion for the fourth consecutive year.
Net sales decreased by 1.3% year-over-year to ¥230.3 billion, while net profit attributable to owners of parent rose 13.1% to ¥9,123 million.
Continued implementation of the medium-term management plan, focusing on global growth, digital transformation, and the "Chori Innovation Plan 2025."
Advanced company-wide business transformation project, including SAP-based mission-critical system (CARAT) implementation, on track for April 2025 launch.
Invested in PT. TAKAHA MULTICHEM INDONESIA, expanding presence in cosmetics raw materials.
Financial highlights
Net sales: ¥230.3 billion, down 1.3% year-over-year.
Operating profit: ¥10.5 billion, down 11.8% year-over-year.
Ordinary profit: ¥12.0 billion, up 1.7% year-over-year; profit before income taxes: ¥12.7 billion, up 6.7% year-over-year.
Net profit attributable to owners of parent: ¥9.1 billion, up 13.1% year-over-year.
Basic earnings per share for nine months: ¥370.23, up from ¥327.65 year-over-year.
Outlook and guidance
FY03/2025 full-year forecast remains unchanged: net sales ¥320.0 billion (+4.0% YoY), operating profit ¥15.0 billion (–0.3%), ordinary profit ¥15.0 billion (+3.6%), net profit attributable to owners of parent ¥10.0 billion (+3.9%), EPS ¥405.82.
Progress rates: 72% for net sales, 91.2% for net profit attributable to owners of parent as of Q3.
Latest events from Chori
- Profits and sales rose sharply, led by Chemicals, with double-digit growth forecast for FY2027.8014
Q1 202730 Jul 2026 - Record Q1 profits, improved equity ratio, and strong progress on business transformation.8014
Q1 202521 Jul 2026 - Record-high profits and strong net income growth despite mixed segment results.8014
Q2 202521 Jul 2026 - Record profits and higher dividends achieved, with stable outlook amid global uncertainties.8014
Q4 202521 Jul 2026 - Sales and profits fell YoY, but gross margin improved and full-year guidance is unchanged.8014
Q1 202621 Jul 2026 - Profits and sales fell YoY, but gross margin, financial stability, and guidance were maintained.8014
Q2 202621 Jul 2026 - Profits and sales fell YoY, but full-year guidance and dividend forecast were raised.8014
Q3 202621 Jul 2026 - Net profit rose 3.0% despite lower sales, with a higher dividend payout ratio set for next year.8014
Q4 202621 Jul 2026